306 related articles for article (PubMed ID: 10683258)
21. Selective binding of monovalent cations to the stacking G-quartet structure formed by guanosine 5'-monophosphate: a solid-state NMR study.
Wong A; Wu G
J Am Chem Soc; 2003 Nov; 125(45):13895-905. PubMed ID: 14599230
[TBL] [Abstract][Full Text] [Related]
22. Photoaffinity labeling with the activator IMP and site-directed mutagenesis of histidine 995 of carbamoyl phosphate synthetase from Escherichia coli demonstrate that the binding site for IMP overlaps with that for the inhibitor UMP.
Bueso J; Cervera J; Fresquet V; Marina A; Lusty CJ; Rubio V
Biochemistry; 1999 Mar; 38(13):3910-7. PubMed ID: 10194302
[TBL] [Abstract][Full Text] [Related]
23. Role of lysine-256 in Citrobacter freundii tyrosine phenol-lyase in monovalent cation activation.
Phillips RS; Chen HY; Shim D; Lima S; Tavakoli K; Sundararaju B
Biochemistry; 2004 Nov; 43(45):14412-9. PubMed ID: 15533046
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of inosine monophosphate dehydrogenase (IMPDH) by 2-[2-(Z)-fluorovinyl]inosine 5'-monophosphate.
Nair V; Kamboj RC
Bioorg Med Chem Lett; 2003 Feb; 13(4):645-7. PubMed ID: 12639549
[TBL] [Abstract][Full Text] [Related]
25. Human IMP dehydrogenase catalyzes the dehalogenation of 2-fluoro- and 2-chloroinosine 5'-monophosphate in the absence of NAD.
Antonino LC; Wu JC
Biochemistry; 1994 Feb; 33(7):1753-9. PubMed ID: 7906542
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of IMPDH by mycophenolic acid: dissection of forward and reverse pathways using capillary electrophoresis.
Fleming MA; Chambers SP; Connelly PR; Nimmesgern E; Fox T; Bruzzese FJ; Hoe ST; Fulghum JR; Livingston DJ; Stuver CM; Sintchak MD; Wilson KP; Thomson JA
Biochemistry; 1996 Jun; 35(22):6990-7. PubMed ID: 8679523
[TBL] [Abstract][Full Text] [Related]
27. Membrane-bound pyrophosphatase of Thermotoga maritima requires sodium for activity.
Belogurov GA; Malinen AM; Turkina MV; Jalonen U; Rytkönen K; Baykov AA; Lahti R
Biochemistry; 2005 Feb; 44(6):2088-96. PubMed ID: 15697234
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the novel Trypanosoma brucei inosine 5'-monophosphate dehydrogenase.
Bessho T; Morii S; Kusumoto T; Shinohara T; Noda M; Uchiyama S; Shuto S; Nishimura S; Djikeng A; Duszenko M; Martin SK; Inui T; Kubata KB
Parasitology; 2013 May; 140(6):735-45. PubMed ID: 23369253
[TBL] [Abstract][Full Text] [Related]
29. Guanidine derivatives rescue the Arg418Ala mutation of Tritrichomonas foetus IMP dehydrogenase.
Guillén Schlippe YV; Hedstrom L
Biochemistry; 2005 Dec; 44(50):16695-700. PubMed ID: 16342959
[TBL] [Abstract][Full Text] [Related]
30. Kinetic and thermodynamic analysis of the interaction of cations with dialkylglycine decarboxylase.
Liu W; Toney MD
Biochemistry; 2004 May; 43(17):4998-5010. PubMed ID: 15109259
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
McMillan FM; Cahoon M; White A; Hedstrom L; Petsko GA; Ringe D
Biochemistry; 2000 Apr; 39(15):4533-42. PubMed ID: 10758003
[TBL] [Abstract][Full Text] [Related]
32. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.
Felczak K; Chen L; Wilson D; Williams J; Vince R; Petrelli R; Jayaram HN; Kusumanchi P; Kumar M; Pankiewicz KW
Bioorg Med Chem; 2011 Mar; 19(5):1594-605. PubMed ID: 21324702
[TBL] [Abstract][Full Text] [Related]
33. Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones.
Barnes BJ; Eakin AE; Izydore RA; Hall IH
Biochemistry; 2000 Nov; 39(45):13641-50. PubMed ID: 11076502
[TBL] [Abstract][Full Text] [Related]
34. Probing the active site of human IMP dehydrogenase using halogenated purine riboside 5'-monophosphates and covalent modification reagents.
Antonino LC; Straub K; Wu JC
Biochemistry; 1994 Feb; 33(7):1760-5. PubMed ID: 7906543
[TBL] [Abstract][Full Text] [Related]
35. Inosine 5'-monophosphate dehydrogenase.
Pimkin M; Markham GD
Adv Enzymol Relat Areas Mol Biol; 2009; 76():1-53. PubMed ID: 18990827
[No Abstract] [Full Text] [Related]
36. Allosteric properties of inosine monophosphate dehydrogenase revealed through the thermodynamics of binding of inosine 5'-monophosphate and mycophenolic acid. Temperature dependent heat capacity of binding as a signature of ligand-coupled conformational equilibria.
Bruzzese FJ; Connelly PR
Biochemistry; 1997 Aug; 36(34):10428-38. PubMed ID: 9265623
[TBL] [Abstract][Full Text] [Related]
37. Active-site modification of native and mutant forms of inosine 5'-monophosphate dehydrogenase from Escherichia coli K12.
Gilbert HJ; Drabble WT
Biochem J; 1980 Nov; 191(2):533-41. PubMed ID: 6112982
[TBL] [Abstract][Full Text] [Related]
38. The conformation of NADH bound to inosine 5'-monophosphate dehydrogenase determined by transferred nuclear Overhauser effect spectroscopy.
Schalk-Hihi C; Zhang YZ; Markham GD
Biochemistry; 1998 May; 37(20):7608-16. PubMed ID: 9585576
[TBL] [Abstract][Full Text] [Related]
39. A potent "fat base" nucleotide inhibitor of IMP dehydrogenase.
Wang W; Hedstrom L
Biochemistry; 1998 Aug; 37(34):11949-52. PubMed ID: 9718319
[TBL] [Abstract][Full Text] [Related]
40. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
Vethe NT; Bergan S
Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
